Zhejiang Huahai Pharmaceutical Co., Ltd.

FDA inspection history across 2 sites, 2017 to 2024

3
Form 483s
1
Close-out
1
EIR

Every document, by year

  • Form 483
  • Close-out
  • EIR

2017: one Form 483; 2018: one close-out letter, one inspection report and one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017–18Two Form 483s, one close-out letter and one inspection report, at Dugiao, China and Linhai, China.
  2. 2018The longest 483 on file: 11 observations over 11 pages at Linhai, China.
  3. 2024One Form 483, at Linhai, China.

Cited most

Across all Zhejiang Huahai Pharmaceutical Co. observations on file

The complete Zhejiang Huahai Pharmaceutical Co. file.

All 5 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$804$946

15% off buying them one by one

Sites

Also: one document not tied to a site.

Documents

5 on file, newest first
DateDocumentPrice
2024-11-20483 Form 483$99
2018-11-29Close-out Close-out letter$99
2018-08-21EIR EIR$550
2018-08-03483 Form 483$99
2017-05-19483 Form 483$99

FEI number 3003885745 · most recent document Nov 20, 2024

About Zhejiang Huahai Pharmaceutical Co., Ltd.

How many FDA Form 483s has Zhejiang Huahai Pharmaceutical Co., Ltd. received?

FDA Intel has 3 Form 483s on file for Zhejiang Huahai Pharmaceutical Co., Ltd.; the most recent is dated Nov 20, 2024.

When was Zhejiang Huahai Pharmaceutical Co., Ltd. last inspected by FDA?

The most recent FDA inspection document on file for Zhejiang Huahai Pharmaceutical Co., Ltd. is a Form 483 dated Nov 20, 2024, for the site in Linhai, China.

What did FDA cite at Zhejiang Huahai Pharmaceutical Co., Ltd.?

The regulations cited most in the observations on file for Zhejiang Huahai Pharmaceutical Co., Ltd. are 21 CFR 211.192 (Production record review), 7 times; 21 CFR 211.67 (Equipment cleaning and maintenance), 5 times; 21 CFR 211.100 (Written procedures; deviations), 3 times.